Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

FDA Approves FreeStyle Libre System for Adults

FDA news release; 2017 Sep 27

The FDA has approved the FreeStyle Libre Flash Glucose Monitoring System, a continuous glucose monitoring system for adults not requiring blood samples calibration. The system is available from Abbott Diabetes Care Inc., Abbott Park, IL, and can be used by adult patients with diabetes to make diabetes treatment decisions without calibration using a blood sample from the fingertip.

The system reduces the need for “fingerstick” testing by using a small sensor wire inserted below the skin’s surface that continuously measures and monitors glucose levels. Users can determine glucose levels by waving a dedicated, mobile reader above the sensor wire to determine if glucose levels are too high to too low, and how glucose levels are changing. After a 12-hour start-up period, the device can be worn for up to 10 days.

Citation:

US Food and Drug Administration. FDA approves first continuous glucose monitoring system for adults not requiring blood sample calibration. FDA Web site. September 27, 2017. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm577890.htm. Accessed October 1, 2017.

This Week's Must Reads

ACP Guideline for HBV Vaccination & Screening, Ann Intern Med; ePub 2017 Nov 21; Abara, et al

Is Coffee Consumption Safe at All Levels?, BMJ; ePub 2017 Nov 22; Poole, Kennedy, et al

Cardiorespiratory Fitness & TG to HDL-C Ratio in CHD, Mayo Clin Proc; ePub 2017 Nov 17; Farrell, et al

Severe Hypoglycemia in Adults with Diabetes, Diabetes Care; 2017 Dec; Lee, Lee, Huang, et al

FDA Approves Epinephrine Autoinjector for Infants, Kaléo news release; 2017 Nov 20

Must Reads in Diabetes

Severe Hypoglycemia in Adults with Diabetes, Diabetes Care; 2017 Dec; Lee, Lee, Huang, et al

Sustainability of Diabetes Prevention Strategies, JAMA Intern Med; ePub 2017 Nov 6; Haw, et al

Trends in Antidiabetes Drug Usage in US, Diabetes Care; ePub 2017 Nov 6; Montvida, et al

Oral Semaglutide for Glycemic Control in T2D, JAMA; 2017 Oct 17; Davies, Pieber, et al

Vitamin D & Glycemic Control in Patients with T2D, J Clin Endocrinol Metab; 2017 Sep 1; Mirhosseini, et al